| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 30 Jan 2026 | 26 Dec 2025 |
| Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Unaudited Financial Results for the quarter ended December 31, 2025. Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve The Company has submitted an update on Board Meeting scheduled to be held on January 30, 2026. (As per BSE announcement dated on : 21.01.2026) Dear Sir, Please find enclosed the Financial Results for the quarter ended December 31, 2025. (As per BSE announcement dated on : 30.01.2026) | ||
| Board Meeting | 6 Nov 2025 | 29 Sep 2025 |
| Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve Intimation of Board Meeting scheduled to be held on November 6 2025 Purpose of the meeting has been revised (As Per BSE Announcement Dated On : 15.10.2025) Dear Sir, Please find attached Outcome of Board Meeting held on November 6, 2025 (As per BSE Announcement dated on: 06.11.2025) | ||
| Board Meeting | 30 Jul 2025 | 27 Jun 2025 |
| Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2025 inter alia to consider and approve unaudited financial results for the quarter ended June 302025 Dear Sir, Please find enclosed unaudited results for the quarter ended June 30, 2025 along with limited review report issued by statutory auditors of the Company. (As Per BSE Announcement Dated on :30.07.2025) | ||
| Board Meeting | 23 Jun 2025 | 23 Jun 2025 |
| Find enclosed communication with respect to change in Chief Financial Officer of the Company. | ||
| Board Meeting | 27 May 2025 | 26 Mar 2025 |
| Procter & Gamble Hygiene And Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2025 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday May 27 2025 inter alia to consider and approve Audited Financial Results and Statements for the Financial Year ended March 312025 and to consider recommendation of dividend if any. Find enclosed the audited financial results for the year ended March 31,2025 along with the report of the auditors there on. Further, the Board has recommended a final dividend of Rs. 65 per share for the financial year 2024-25. Also, the Board has approved appointment of secretarial auditors for a tenure of five years effective April 1,2025 (As Per BSE Announcement dated on 27.05.2025) | ||
Revenue from operations showed a marginal increase during the quarter, rising to ₹1,261.90 crore, compared with ₹1,247.63 crore in the corresponding period last year
The company, which follows the July-June financial year, declared a profit after tax of ₹210.69 Crore in the same quarter of the previous year.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.